{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:13:48Z","timestamp":1791378828676,"version":"4.3.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Angel Program \"Caring for Life\" Thalassemia Rescue Project from Red Cross Society of China Guangxi Branch"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69756-8","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:05:45Z","timestamp":1771859145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A multi-center clinical trial of allogeneic hematopoietic stem cell transplantation in transfusion-dependent thalassemia"],"prefix":"10.1038","volume":"17","author":[{"given":"Rongrong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-1195","authenticated-orcid":false,"given":"Jiong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanye","family":"Nai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuande","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4761-0220","authenticated-orcid":false,"given":"Borje S.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-1954","authenticated-orcid":false,"given":"Yongrong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"69756_CR1","doi-asserted-by":"crossref","unstructured":"Kato, G. J. et al. Sickle cell disease. Nat. Rev. Dis. Primers 4, 18010 (2018).","DOI":"10.1038\/nrdp.2018.10"},{"key":"69756_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"2008","author":"B Modell","year":"2008","unstructured":"Modell, B. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ. 2008, 480\u2013487 (2008).","journal-title":"Bull. World Health Organ."},{"key":"69756_CR3","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","volume":"399","author":"A Kattamis","year":"2022","unstructured":"Kattamis, A., Kwiatkowski, J. L. & Aydinok, Y. Thalassaemia. Lancet 399, 2310\u20132324 (2022).","journal-title":"Lancet"},{"key":"69756_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jcyt.2021.09.003","volume":"24","author":"A Leonard","year":"2022","unstructured":"Leonard, A. et al. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation. Cytotherapy 24, 249\u2013261 (2022).","journal-title":"Cytotherapy"},{"key":"69756_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","volume":"26","author":"U Anurathapan","year":"2020","unstructured":"Anurathapan, U. et al. Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen. Biol. Blood Marrow Transpl. 26, 1106\u20131112 (2020).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"69756_CR6","doi-asserted-by":"publisher","first-page":"963689721994808","DOI":"10.1177\/0963689721994808","volume":"30","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Co-transplantation of haploidentical stem cells and a dose of unrelated cord blood in pediatric patients with thalassemia major. Cell Transpl. 30, 963689721994808 (2021).","journal-title":"Cell Transpl."},{"key":"69756_CR7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.bbmt.2020.03.016","volume":"26","author":"VV Swaminathan","year":"2020","unstructured":"Swaminathan, V. V. et al. Matched family versus alternative donor hematopoietic stem cell transplantation for patients with thalassemia major: experience from a tertiary referral center in South India. Biol. Blood Marrow Transpl. 26, 1326\u20131331 (2020).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"69756_CR8","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/bloodadvances.2019000291","volume":"3","author":"C Li","year":"2019","unstructured":"Li, C. et al. Related and unrelated donor transplantation for \u03b2-thalassemia major: results of an international survey. Blood Adv. 3, 2562\u20132570 (2019).","journal-title":"Blood Adv."},{"key":"69756_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41409-023-01980-y","volume":"58","author":"A Nagler","year":"2023","unstructured":"Nagler, A. et al. Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP\/EBMT. Bone Marrow Transpl. 58, 791\u2013800 (2023).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR10","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.bbmt.2019.06.009","volume":"25","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. G-CSF-mobilized blood and bone marrow grafts as the source of stem cells for HLA-identical sibling transplantation in patients with thalassemia major. Biol. Blood Marrow Transpl. 25, 2040\u20132044 (2019).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"69756_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/bmt.2015.293","volume":"51","author":"D Baronciani","year":"2016","unstructured":"Baronciani, D. et al. Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transpl. 51, 536\u2013541 (2016).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41409-022-01613-w","volume":"57","author":"MA Yesilipek","year":"2022","unstructured":"Yesilipek, M. A. et al. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience. Bone Marrow Transpl. 57, 760\u2013767 (2022).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fimmu.2016.00362","volume":"7","author":"S Masouridi-Levrat","year":"2016","unstructured":"Masouridi-Levrat, S., Simonetta, F. & Chalandon, Y. Immunological basis of bone marrow failure after allogeneic hematopoietic stem cell transplantation. Front. Immunol. 7, 362 (2016).","journal-title":"Front. Immunol."},{"key":"69756_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson, R. F. et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia 29, 1754\u20131762 (2015).","journal-title":"Leukemia"},{"key":"69756_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/bmt.2012.239","volume":"48","author":"R Olsson","year":"2013","unstructured":"Olsson, R. et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transpl. 48, 537\u2013543 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/bmt.2011.219","volume":"47","author":"E Goussetis","year":"2012","unstructured":"Goussetis, E. et al. HLA-matched sibling stem cell transplantation in children with \u03b2-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience. Bone Marrow Transpl. 47, 1061\u20131066 (2012).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang, X. H. et al. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J. Hematol. Oncol. 14, 145 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"69756_CR18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1200\/JCO.2015.63.8817","volume":"34","author":"YJ Chang","year":"2016","unstructured":"Chang, Y. J. et al. Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation. J. Clin. Oncol. 34, 1855\u20131863 (2016).","journal-title":"J. Clin. Oncol."},{"key":"69756_CR19","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","volume":"107","author":"ZL Xu","year":"2022","unstructured":"Xu, Z. L. et al. Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study. Haematologica 107, 2918\u20132927 (2022).","journal-title":"Haematologica"},{"key":"69756_CR20","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn, V. et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92, 2303\u20132314 (1998).","journal-title":"Blood"},{"key":"69756_CR21","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash, R. A. et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96, 2062\u20132068 (2000).","journal-title":"Blood"},{"key":"69756_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/03630269.2022.2059671","volume":"46","author":"U Anurathapan","year":"2022","unstructured":"Anurathapan, U. et al. Haploidentical hematopoietic stem cell transplantation in thalassemia. Hemoglobin 46, 2\u20136 (2022).","journal-title":"Hemoglobin"},{"key":"69756_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1182\/bloodadvances.2017012005","volume":"2","author":"J Gaziev","year":"2018","unstructured":"Gaziev, J. et al. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCR\u03b1\u03b2(+)\/CD19(+)-depleted grafts. Blood Adv. 2, 263\u2013270 (2018).","journal-title":"Blood Adv."},{"key":"69756_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood-2022-166003","volume":"140","author":"RR Liu","year":"2022","unstructured":"Liu, R. R. et al. Basiliximab in the prevention of aGVHD for unrelated donor hematopoietic stem cell transplantation in patients with thalassemia major: a prospective, multicenter, open-label, randomized controlled study. Blood 140, 1383\u20131384 (2022).","journal-title":"Blood"},{"key":"69756_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson, A. A. et al. Gene therapy in patients with transfusion-dependent \u03b2-thalassemia. N. Engl. J. Med. 378, 1479\u20131493 (2018).","journal-title":"N. Engl. J. Med."},{"key":"69756_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa2113206","volume":"386","author":"F Locatelli","year":"2022","unstructured":"Locatelli, F. et al. Betibeglogene autotemcel gene therapy for non-\u03b2(0)\/\u03b2(0) genotype \u03b2-thalassemia. N. Engl. J. Med. 386, 415\u2013427 (2022).","journal-title":"N. Engl. J. Med."},{"key":"69756_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N. Engl. J. Med. 384, 252\u2013260 (2021).","journal-title":"N. Engl. J. Med."},{"key":"69756_CR28","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1182\/blood-2018-99-118325","volume":"132","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Effects of splenectomy before transplantation on \u03b2-thalassaemia major with matched sibling and unrelated hematopoietic stem cell transplantation. Blood 132, 5782\u20135782 (2018).","journal-title":"Blood"},{"key":"69756_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28483","volume":"67","author":"K Sanpakit","year":"2020","unstructured":"Sanpakit, K. et al. Impact of splenectomy on outcomes of hematopoietic stem cell transplantation in pediatric patients with transfusion-dependent thalassemia. Pediatr. Blood Cancer 67, e28483 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"69756_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41409-021-01233-w","volume":"56","author":"X Lai","year":"2021","unstructured":"Lai, X. et al. Hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome. Bone Marrow Transpl. 56, 1635\u20131641 (2021).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR31","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41409-022-01663-0","volume":"57","author":"H Liang","year":"2022","unstructured":"Liang, H. et al. Health-related quality of life in pediatric patients with \u03b2-thalassemia major after hematopoietic stem cell transplantation. Bone Marrow Transpl. 57, 1108\u20131115 (2022).","journal-title":"Bone Marrow Transpl."},{"key":"69756_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s11096-017-0481-z","volume":"39","author":"JJ Huang","year":"2017","unstructured":"Huang, J. J., Chen, B., Hu, J. & Yang, W. H. Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients. Int. J. Clin. Pharm. 39, 662\u2013668 (2017).","journal-title":"Int. J. Clin. Pharm."},{"key":"69756_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bjh.13267","volume":"169","author":"L Tucunduva","year":"2015","unstructured":"Tucunduva, L. et al. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. Br. J. Haematol. 169, 103\u2013110 (2015).","journal-title":"Br. J. Haematol."},{"key":"69756_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan, S. G. et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 125, 1333\u20131338 (2015).","journal-title":"Blood"},{"key":"69756_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald, G. B., Sharma, P., Matthews, D. E., Shulman, H. M. & Thomas, E. D. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4, 116\u2013122 (1984).","journal-title":"Hepatology"},{"key":"69756_CR36","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2012-03-417998","volume":"120","author":"C Li","year":"2012","unstructured":"Li, C. et al. A novel conditioning regimen improves outcomes in \u03b2-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood 120, 3875\u20133881 (2012).","journal-title":"Blood"},{"key":"69756_CR37","unstructured":"Li, Q., Wu, M., Zhang, Z., Liu, L. & Lai, Y. Unrelated donor peripheral blood stem cell transplantation for thalassaemia: a single institution experience of 53 patients. Blood 130, 357 (2017)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69756-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:19:28Z","timestamp":1774984768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69756-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69756"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69756-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3083"}}